You are here

vaccines

Vaccine alliance finds manufacturing capacity for 4 billion doses of coronavirus vaccines

Vaccine alliance finds manufacturing capacity for 4 billion doses of coronavirus vaccines

Reuters

drug manufacturing

Flag link:

Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal

Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal

Fierce Pharma

Moderna Therapeutics

Flag link:

Fauci: Trump never asked to slow down testing, 'cautiously optimistic' about vaccine by 2021

Fauci: Trump never asked to slow down testing, 'cautiously optimistic' about vaccine by 2021

BioPharma Dive

Flag link:

AstraZeneca COVID-19 Vaccine Shows Promise in 2-Dose Animal Trial

AstraZeneca COVID-19 Vaccine Shows Promise in 2-Dose Animal Trial

Motley Fool

Pirbright Institute

animal research

Flag link:

Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device

Inovio gets $71 mln from U.S. DoD for COVID-19 vaccine device

Reuters

Department of Defense

Flag link:

Sanofi’s third Translate collaboration sees big bucks at last

Sanofi’s third Translate collaboration sees big bucks at last

EP Vantage

Flag link:

Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies

Merck’s Experimental Pneumonia Vaccine Hits the Mark in Two Phase III Studies

BioSpace

clinical trials

pneumococcal disease

Flag link:

MMR Vaccine Could Invigorate the Innate Immune System to Fight COVID-19

MMR Vaccine Could Invigorate the Innate Immune System to Fight COVID-19

BioSpace

Flag link:

Roche, BioNTech post 'low' response rate in cancer vaccine trial

Roche, BioNTech post 'low' response rate in cancer vaccine trial

Fierce Biotech

personalized medicine

clinical trials

Flag link:

How Moderna's Second Worst Nightmare Could Become a Reality

How Moderna's Second Worst Nightmare Could Become a Reality

Motley Fool

Moderna Therapeutics

Flag link:

Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team

Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team

Marketwatch

2020 Presidential election

Flag link:

Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August

Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August

Fierce Biotech

Clover BioPharmaceuticals

Flag link:

Novavax Taps Ex-AstraZeneca Executive as CMO, Will Head Corornavirus Vaccine Development

Novavax Taps Ex-AstraZeneca Executive as CMO, Will Head Corornavirus Vaccine Development

Motley Fool

Flag link:

'Warp Speed' plan for coronavirus vaccines comes into focus

'Warp Speed' plan for coronavirus vaccines comes into focus

BioPharma Dive

Operation Warp Speed

drug development

Flag link:

Moderna Seals Deal to Supply Israel with Coronavirus Vaccine

Moderna Seals Deal to Supply Israel with Coronavirus Vaccine

Motley Fool

Moderna Therapeutics

Flag link:

CureVac gets OK to start testing mRNA COVID-19 vaccine in humans

CureVac gets OK to start testing mRNA COVID-19 vaccine in humans

Fierce Pharma

clinical trials

Flag link:

AstraZeneca CEO Soriot says fast-tracked COVID-19 shot will protect for just one year

AstraZeneca CEO Soriot says fast-tracked COVID-19 shot will protect for just one year

Fierce Pharma

University of Oxford

Flag link:

Sanofi pumps $554M into new vaccine manufacturing facility in eastern France

Sanofi pumps $554M into new vaccine manufacturing facility in eastern France

Fierce Pharma

drug manufacturing

Flag link:

Germany stakes its claim over Curevac

Germany stakes its claim over Curevac

EP Vantage

Flag link:

Novavax Raising $200 Million to Fund Coronavirus and Flu Vaccine Efforts

Novavax Raising $200 Million to Fund Coronavirus and Flu Vaccine Efforts

Motley Fool

Flag link:

Pages